| |
| |
|
| Insider
Information: |
Brum Lynne H |
| Relationship: |
VP, Planning and Corpo... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
154,525 |
|
|
Indirect Shares
|
856,224 |
|
|
| Direct
Value |
$20,381,956 |
|
|
|
Indirect Value
|
$3,004,933 |
|
|
| Total
Shares |
1,010,749 |
|
|
| Total
Value |
$23,386,889 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
VP, Strategic Communic... |
2006-05-08 |
46,199 |
2006-05-08 |
6,803 |
Premium* |
|
|
Altus Pharmaceuticals Inc. |
ALTUQ |
Director |
|
0 |
2006-01-31 |
817,749 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
VP, Planning and Corpo... |
2024-02-15 |
108,326 |
2024-02-15 |
31,672 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
60 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
VP, Corp. Comm.&Financial Plan |
• – – |
2003-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
800 |
6,021 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Corp. Comm.&Financial Plan |
• – – |
2004-03-17 |
4 |
A |
$0.01 |
$8 |
D/D |
800 |
6,821 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Corp. Comm.&Financial Plan |
• – – |
2004-05-06 |
4 |
A |
$0.01 |
$350 |
D/D |
35,000 |
41,821 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Corp. Comm.&Financial Plan |
• – – |
2005-02-03 |
4 |
A |
$0.01 |
$24 |
D/D |
2,375 |
44,196 |
|
- |
|
| ALTUQ |
Altus Pharmaceuticals Inc... |
officerTitle |
– • – |
2006-01-31 |
4 |
A |
$0.00 |
$0 |
I/I |
381,596 |
817,749 |
|
- |
|
| YTEN |
Yield10 Bioscience Inc |
VP Marketing and Corp Comm |
• – – |
2015-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
544,405 |
554,405 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
VP Planning & Comms |
• – – |
2020-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
4,186 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
VP Planning & Comms |
• – – |
2021-03-01 |
4 |
A |
$16.03 |
$33,535 |
D/D |
2,092 |
4,998 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
VP Planning and Comms |
• – – |
2022-02-10 |
4 |
A |
$3.83 |
$22,563 |
D/D |
5,891 |
10,582 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
VP, Planning and Corporate Com |
• – – |
2024-02-15 |
4 |
A |
$0.30 |
$30,000 |
D/D |
100,000 |
108,326 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2005-12-06 |
4 |
AS |
$24.80 |
$49,600 |
D/D |
(2,000) |
44,196 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2006-01-17 |
4 |
AS |
$33.62 |
$33,620 |
D/D |
(1,000) |
44,196 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2006-01-23 |
4 |
AS |
$33.63 |
$33,630 |
D/D |
(1,000) |
44,196 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2006-01-31 |
4 |
AS |
$35.29 |
$35,290 |
D/D |
(1,000) |
44,196 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2006-02-06 |
4 |
AS |
$34.33 |
$34,330 |
D/D |
(1,000) |
48,587 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-02-13 |
4 |
AS |
$34.96 |
$34,960 |
D/D |
(1,000) |
48,587 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-02-21 |
4 |
AS |
$37.13 |
$37,130 |
D/D |
(1,000) |
48,587 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-02-27 |
4 |
AS |
$43.87 |
$43,870 |
D/D |
(1,000) |
48,587 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-03-06 |
4 |
AS |
$43.94 |
$43,940 |
D/D |
(1,000) |
48,587 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-03-13 |
4 |
AS |
$37.23 |
$37,230 |
D/D |
(1,000) |
48,587 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-03-20 |
4 |
AS |
$35.87 |
$35,870 |
D/D |
(1,000) |
46,199 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-03-20 |
4 |
AS |
$40.12 |
$56,168 |
D/D |
(1,400) |
48,187 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-03-24 |
4 |
AS |
$36.56 |
$72,681 |
D/D |
(1,988) |
46,199 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-04-03 |
4 |
AS |
$35.98 |
$35,980 |
D/D |
(1,000) |
46,199 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-04-10 |
4 |
AS |
$33.92 |
$33,920 |
D/D |
(1,000) |
46,199 |
|
- |
|
60 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
